Transamerica Life Insurance After Being Declined Fit Review

Research Snapshot

Why Transamerica Qualified for This Study

Questions This Section Answers

• Is Transamerica a good choice for life insurance after being declined by another carrier?
• How many AI platforms named Transamerica for life insurance after a decline, and at what rank?

Transamerica qualified because four of the seven platforms named it during ranking discovery, with an average listed rank of 2.75 and a best rank of 1 (grok, kimi). The remaining three platforms evaluated fit but did not name the carrier in the ranking stage, so the mention count reflects ranking discovery only, not overall evaluation.

The carrier's relevance rests on a product line built for applicants who may struggle with traditional underwriting. Transamerica markets a Final Expense Solutions Portfolio using simplified-issue whole life insurance, with coverage generally from $1,000 to $50,000 and issue ages up to 85, subject to product and state limits ^[1]. Independent reviews describe medical exams as not required for whole or final expense coverage and potentially waived for certain term applicants ^[3].

Platform fit ratings split: anthropic, kimi, and perplexity rated Transamerica a "good" fit; openai, deepseek, google, and grok rated it "mixed." That split is the central finding of this review. The product design is accessible, but no platform treated approval as guaranteed.

The Product, Model, Plan, or Service Most Relevant to Life Insurance After Being Declined

Questions This Section Answers

• Which Transamerica product should a buyer choose after being declined for final expense coverage?
• Is Transamerica's simplified-issue final expense policy guaranteed approval after a prior decline?

The most relevant Transamerica offering is its simplified-issue final expense whole life line, not its term products. The portfolio includes Immediate Solution, 10-Pay Solution, and Easy Solution, with issue ages, coverage limits, premium-payment periods, and a graded risk classification for Easy Solution ^[4]. FE Express Solution was introduced as the newest addition to that suite ^[5].

Product naming is inconsistent across platforms and sources, and buyers should not assume the names are interchangeable. Ranking-stage outputs referenced "Final Expense Express Solution," "Graded FE Express Solution," and "Living Solutions Final Expense," while reviewed public materials use names such as Immediate Solution, 10-Pay Solution, Easy Solution, Trendsetter Super Series, and Trendsetter LB ^[4]. The exact currently available product name and state-specific version is unclear from the reviewed sources.

For term coverage, Transamerica's Trendsetter materials describe point-of-sale or accelerated underwriting without exams for qualifying applicants, with possible continuation to traditional underwriting that can result in a lower premium, higher premium, or decline ^[8]. Independent reviews describe Trendsetter Super as offering up to $2 million in term coverage without a medical exam for qualified applicants ^[9].

Critically, no reviewed source establishes that these products are guaranteed-issue policies. Simplified issue and graded benefits should not be treated as guaranteed approval ^[11]. Transamerica's own underwriting field guide states the company does not currently offer standard guaranteed issue policies ^[13].

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree Transamerica offers for applicants declined elsewhere?
• Does Transamerica require a medical exam for final expense coverage after a decline?

Platforms agreed on three points: no-exam access, simplified-issue positioning, and the absence of guaranteed approval.

On no-exam access, the agreement was strong. Transamerica states that no medical exam is required for simplified-issue final expense coverage and that its term line offers no-medical-exam coverage for qualifying applicants ^[14]. Independent reviews corroborate that medical exams are not required for whole or final expense coverage ^[16], and that FE Express and Graded FE Express both require no medical exams ^[17].

On product positioning, platforms agreed the final expense line is the primary fit after a decline. Transamerica's final expense products are whole life insurance with guaranteed level premiums and permanent lifetime protection, designed for end-of-life expenses ^[14]. The portfolio is described as offering face amounts from $5,000 to $50,000 on the final expense product page ^[14].

On speed, platforms agreed the application path is fast. Transamerica markets FE Express as a digital experience with policy delivery in as little as 10 minutes or less in most cases ^[18], and independent reviews describe 100% instant decisions and electronic policy delivery in as fast as 10 minutes ^[21].

On the absence of guaranteed approval, agreement was unanimous across every platform that addressed it. FE Express is explicitly not guaranteed issue ^[18], and eligibility and premiums remain subject to underwriting ^[18].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• Does a prior decline by another carrier affect a new Transamerica application?
• Is Transamerica a guaranteed-issue carrier for applicants with serious health conditions?

The sharpest disagreement concerns prior declines and Transamerica's own decline history. Google reported that applications on proposed insureds previously declined for another life product with any Transamerica insurance company will be declined ^[22], and that Solutions applications are not designed or priced to accept risks previously determined uninsurable by Transamerica ^[23]. Grok separately reported that a prior Transamerica decline within 24 months typically results in decline ^[24]. No other platform surfaced this rule, and the reviewed sources do not establish whether a decline by a different carrier creates an automatic exclusion, a postponement period, or merely additional underwriting (openai).

Coverage maximums conflict. Transamerica's own pages support up to $50,000 ^[25], while some third-party reviews claim different limits or age ranges, including $100,000 for FE Express at younger ages ^[27]. One independent source reports a graded FE Express maximum face amount of $25,000 ^[29]. Buyers should verify the limit for their age band and state rather than relying on any single figure.

Graded benefit structures also conflict. One source describes Easy Solution as paying 30% of face value in year one and 70% in year two, with full coverage in year three ^[30]. Another describes a two-year graded death-benefit period for Easy Solution ^[31], and a third describes non-accidental death during the first two policy years paying 110% of premiums paid ^[32]. Google noted these structures vary by state law and policy form.

High-risk occupation treatment is uncertain. Perplexity cited underwriting guidance indicating special-hazard occupations such as aviation, military, construction, mining, and professional athletes may be considered with possible flat extra charges ^[33]. OpenAI reported that reviewed public sources do not verify a current consumer-facing term product specifically promising special acceptance treatment for high-risk occupations (openai).

Customer service evidence is one-sided but not contradicted. Multiple independent sources report a 2025 customer complaint rate over four times higher than expected ^[34], an NAIC complaint index above 1.0 ^[36], and 334 complaints closed through BBB in the past three years ^[37]. Complaints cluster around servicing rather than claims ^[38]. No platform disputed these findings, but no platform independently verified them either.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What coverage amounts and ages does Transamerica's final expense portfolio offer after a decline?
• How does Transamerica's graded benefit work for applicants with serious health conditions?

The features most relevant after a decline are simplified issue, graded benefits, instant decisioning, and multiple premium-payment structures.

Simplified issue is the core mechanism. Transamerica assesses whether health conditions meaningfully increase risk rather than automatically declining applicants based on medical history ^[39]. The company is described as more lenient on paired health conditions ^[40] and flexible with diabetics before age 45 ^[41]. It is also described as among the top three quoting targets for tobacco, build, controlled diabetes, and sleep apnea cases ^[42].

Graded benefits provide a fallback. Easy Solution is identified as a graded-risk-class product ^[43], and public materials describe a graded death-benefit period ^[44]. One independent source describes the graded structure as paying 110% of premiums for non-accidental death during the first two years, with the full face amount paid after two years regardless of cause ^[45].

Coverage and age ranges vary by product. FE Express Solution is described as available ages 18-85 with the graded option up to 80, and Immediate Solution ages 0-85 ^[47]. FE Express coverage is described as $5,000-$100,000 and Immediate Solution as $1,000-$50,000 by age bands ^[49]. These figures conflict with other sources and should be confirmed.

Payment structure options include lifetime-pay and 10-pay final expense designs ^[43]. Immediate Solution and Easy Solution use level premiums to age 121 according to the product guide, while 10-Pay Solution uses premiums payable for 10 years (openai).

Rider availability varies by state and product, including accelerated death benefit and nursing-home-related benefits ^[50]. The rider chart shows the accelerated death benefit with nursing-home benefit is not uniformly available and may apply only to selected final-expense products ^[50].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Transamerica final expense coverage cost per month after a decline?
• What fees and contract terms apply to a Transamerica policy issued after a prior decline?

No reliable public quote was identified for this buyer profile, and pricing confidence is low across platforms. Premiums are individualized and depend on age, state, sex, smoking status, face amount, payment period, health history, underwriting outcome, and product selection (openai). Transamerica does not publish specific premium rates or fee schedules for its simplified-issue products in a way that is verifiable from public sources without a quote ^[51].

One platform reported a $42.00 annual policy fee (google), but this figure appears in only one platform response and was not corroborated elsewhere. Treat it as platform-reported and unverified.

On contract structure, the products are life insurance contracts with ongoing premium obligations; exact grace-period, lapse, surrender, reinstatement, and free-look provisions are state- and contract-specific (openai). Final expense policies are described as having level premiums guaranteed to age 121 with permanent lifetime coverage (anthropic). Graded policies carry a two-year waiting period on non-accidental death claims, after which the full death benefit applies (anthropic). Policies are subject to a standard two-year contestability and suicide exclusion period (google).

On additional costs, optional riders are available at additional cost, including chronic illness accelerated death benefit, critical illness accelerated death benefit, disability waiver of premium, children's benefit, and accidental death benefit (anthropic). No separate application fee was identified in the reviewed sources (openai). Possible policy charges, rider costs, or surrender-related effects are unclear from the public materials reviewed and must be confirmed in the policy illustration and contract (openai).

Pricing is reported as middle-of-the-pack to competitive for final expense coverage, with rates similar to the national average for ages 50-75, while no-exam policies carry higher premiums due to insurer pricing in greater uncertainty (anthropic).

Best Suited For

Questions This Section Answers

• Who is Transamerica best suited for after a life insurance decline?
• Is Transamerica worth considering for small permanent coverage after a decline?

Transamerica is best suited to applicants seeking modest permanent coverage who may qualify under simplified-issue rules. The clearest fit is an applicant seeking approximately $1,000-$50,000 of permanent coverage for burial or final expenses (openai). A second fit is an applicant whose prior decline involved an underwriting issue that may be acceptable under a simplified-issue or graded-benefit product (openai).

Age and product alignment matter. Applicants within applicable product limits who prefer no exam or lab-based application processing are a reasonable fit (openai), as are applicants needing term coverage who are willing to undergo additional underwriting if accelerated approval is unavailable (openai). One platform described the fit as consumers ages 18-60 seeking no-medical-exam term life after a decline that was carrier-specific rather than based on universally disqualifying conditions (kimi).

Applicants with specific manageable impairments may also fit. Transamerica is described as covering conditions often excluded elsewhere, including congestive heart failure, COPD, diabetes with complications, and Parkinson's disease, with day-one coverage for qualified applicants ^[52]. Buyers who want a 10-year paid-up final expense policy to avoid lifetime premiums are another described fit (google).

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Transamerica for life insurance after being declined?
• What health situations still lead to a Transamerica decline despite simplified issue?

Transamerica is probably not the best fit for applicants needing substantial income-replacement coverage beyond final-expense amounts (openai). The final-expense portfolio generally caps coverage at $50,000, with lower maximums for some ages and products, which is usually inadequate for large mortgage, income-replacement, business-continuation, or estate-planning needs ^[53].

Applicants with severe or recently worsened health conditions where guaranteed-issue coverage may be more appropriate are also a poor fit (openai). Recent cancer treatment within 1-2 years, uncontrolled diabetes, heart attack within the past year, and most serious impairments under active treatment will still be postponed or declined ^[54]. Transamerica does not offer standard guaranteed-issue life insurance with zero medical questions ^[55].

Applicants seeking the lowest possible premium who may qualify for fully underwritten preferred term coverage elsewhere are a weak fit (openai). So are applicants whose prior decline resulted from a condition or lifestyle factor expressly excluded by the selected product's underwriting rules (openai).

Two additional exclusions matter. Anyone previously declined specifically by a Transamerica company faces an automatic decline rule ^[57]. And applicants who value direct-to-consumer online purchasing will find Transamerica sells through independent agents, not directly to consumers, with online quotes only available for Trendsetter Super ^[58].

When Another Option May Be Better

Questions This Section Answers

• When is a guaranteed-issue carrier a better choice than Transamerica after a decline?
• When should a buyer use an independent broker instead of applying directly to Transamerica?

A guaranteed-issue insurer may be better when the buyer has serious health conditions and cannot qualify for simplified-issue or traditionally underwritten coverage, although guaranteed-issue policies commonly have lower limits and waiting-period provisions (openai). One platform specifically named Colonial Penn, Gerber Life, and Mutual of Omaha's guaranteed acceptance products as alternatives for applicants requiring guaranteed-issue coverage (anthropic).

Another carrier may be better when the buyer needs more than final-expense coverage or when a competitor offers more favorable underwriting for the specific declined condition (openai). Fully underwritten term insurance from another carrier may be better when the buyer's health has improved or the prior decline was caused by incomplete, outdated, or correctable information (openai). One platform noted SBLI offers better rates for healthier applicants, positioning Transamerica as best for those with impairments (anthropic).

An independent broker able to compare multiple carriers may be better when the buyer does not know why the prior application was declined or wants to avoid multiple uncoordinated applications (openai). Industry guidance emphasizes that different carriers have different underwriting guidelines and that one carrier's decline can be another's approval ^[60]. Informal underwriting inquiries before formal application can help avoid adding new decline records to an MIB file ^[61].

For buyers in New York State, some Transamerica products are unavailable and state-specific offerings must be verified (anthropic).

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer confirm with Transamerica before submitting a new application after a decline?
• How can a buyer avoid adding another decline to their MIB record?

Verify these items before submitting an application, because a formal application can generate a new decline record.

Confirm whether the exact product is currently available in your state and at your age (openai). Confirm whether the prior decline must be disclosed, and whether Transamerica will obtain or review the prior application, medical records, MIB information, prescription history, or decline reason (openai). Ask whether the offered policy is immediate-benefit, graded-benefit, or modified-benefit, and what exactly is payable during the first two policy years (openai).

Ask what conditions, medications, diagnoses, tobacco use, substance use, driving history, or occupations would cause a decline, postponement, surcharge, or exclusion (openai). For the term product, ask what happens if accelerated underwriting is unsuccessful and whether the application continues without starting a new one (openai). Request the exact premium, payment duration, guaranteed premium schedule, cash value, surrender value, and lapse consequence (openai).

Confirm which riders are available in your state and what they cost (openai). Ask about free-look, contestability, suicide, reinstatement, and beneficiary restrictions in the issued contract (openai). Ask whether another carrier would provide a higher face amount, better underwriting class, or lower premium for the specific reason for the previous decline (openai). Finally, consider whether to apply through an independent broker capable of comparing multiple insurers rather than submitting several applications simultaneously (openai).

One platform recommended asking whether Transamerica's underwriting team will pre-screen your condition informally before you submit a formal application, to avoid adding a decline to your MIB record (anthropic). Another recommended reviewing your MIB file for accuracy and disputing any errors before reapplying (kimi).

Final AI Consensus Verdict

Transamerica is a mixed, potentially worthwhile option rather than a clear first choice for Life Insurance After Being Declined. Its strongest use case is a consumer seeking modest final-expense coverage who may benefit from simplified issue, a graded option, or qualifying nonmedical underwriting. It is a weaker fit for large coverage needs, severe or recent health problems requiring guaranteed issue, or buyers who need transparent pricing and confirmed special underwriting for a high-risk occupation.

The consensus is not that Transamerica is the best carrier for this use case. It is that Transamerica has a genuinely relevant product line, that approval remains underwriting-dependent, and that the buyer's specific decline reason determines whether the fit is good or poor. Platform fit ratings split three "good" to four "mixed," and no platform treated acceptance as guaranteed.

How This Review Was Produced

This review synthesizes structured fit-research responses from seven AI platforms, each evaluating Transamerica against the use case of applying for life insurance after a prior decline. Four platforms named Transamerica during ranking discovery; all seven produced fit assessments. Platform fit ratings were three "good" (anthropic, kimi, perplexity) and four "mixed" (openai, deepseek, google, grok).

The study date is 2026-09-22. Platform-reported research dates are provenance metadata and do not independently prove freshness. One platform reported a research date of 2026-01-15, which differs from the authoritative run date.

Citations are platform-reported evidence, not independently verified facts. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Company-owned sources are distinguished from independent sources in the Sources section below.

Methodology Limitations

Several limitations apply. Platform-reported research dates differ from the authoritative run date, and one platform reported a date roughly eight months earlier than the study date. That platform also ran without search enabled, so its claims require explicit verification before being described as current facts.

Product naming conflicts were not resolved. Ranking-stage outputs and reviewed public materials use different product names, and the exact currently available product name and state-specific version is unclear. Conflicting coverage maximums, graded benefit structures, and age bands were preserved rather than reconciled.

The reviewed sources do not disclose current applicant-specific premiums or a complete underwriting guide for previously declined applicants. Public pricing is insufficient to determine whether Transamerica is competitively priced for this applicant. The reviewed materials do not establish whether a previous decline creates an automatic exclusion, a postponement period, or merely additional underwriting, and high-risk occupation treatment was not verified in the reviewed public sources.

Some product documents are producer-facing or older than the research date, and current state approvals and availability should be confirmed before application. No independent source confirms Transamerica's claim acceptance rates or decline rates after a prior decline. No independent data was found on Transamerica's claim denial rate specifically.

Platform agreement does not prove product quality. The counts in this review describe how many platforms named or assessed Transamerica, not how well the products perform.